Почетна › Dijabetes tipa 2 › Mičigen
Kliničke studije za Dijabetes tipa 2 u državi Mičigen
25 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Mičigen.
Gradovi u državi Mičigen
- Ann Arbor9 студија
- Troy6 студија
- Farmington Hills5 студија
- Detroit5 студија
- Dearborn3 студија
- Flint3 студија
Zvanični tekst studije (na engleskom)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Northern Pines Health Center - Buckley, Buckley
- Revival Research Institute, LLC - Dearborn, Dearborn
- Arcturus Healthcare - Troy Internal Medicine Research Division, Troy
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Revival Research Institute, LLC - Dearborn, Dearborn
- Aa Mrc Llc, Flint
- Elite Research Center, LLC, Flint
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Aa Mrc Llc, Flint
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Revival Research Institute, LLC, Dearborn
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Troy
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Farmington Hills
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Michigan, Ann Arbor
- Elixia Michigan Kidney Consultants, Pontiac
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Southfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Great Lakes Research Inst., Southfield
Тражи се учесникФаза 3
Узраст од 10 до 18 · Оба пола · Ажурирано 19. 10. 2026. · NCT07282613Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
- University of Michigan, Ann Arbor
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 14 до 18 · Оба пола · Ажурирано 15. 10. 2026. · NCT06007404The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Michigan Medicine, Division of Gastroenterology and Hepatology, Ann Arbor
Тражи се учесник
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Oakland Medical Research Center, Troy
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Michigan, Ann Arbor
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Michigan, Ann Arbor
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06906640Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Northern Pines Hlth Ctr, PC, Buckley
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Henry Ford Hospital, Detroit
- Trinity Health Michigan Heart, Ypsilanti
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Southfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Henry Ford Health System, Detroit
- Elite Research Center, Flint
- Arcturus Healthcare, PLC., Troy
- и још 1
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335Mechanisms of Fatigability With Diabetes
- University of Michigan, Ann Arbor
Тражи се учесник
Узраст од 30 до 85 · Оба пола · Ажурирано 1. 9. 2026. · NCT04442451A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Southfield
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT07662044Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Henry Ford Health System, Detroit
Тражи се учесник
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 8. 2026. · NCT07599982Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Henry Ford Health, Detroit
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 8. 2026. · NCT07521475Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Henry Ford Health Systems, Detroit
Тражи се учесник
Узраст од 14 до 75 · Оба пола · Ажурирано 3. 8. 2026. · NCT07579702Mechanism of SGLT2 Inhibition in the Kidney
- University of Michigan, Ann Arbor
Тражи се учесникФаза 4Наводи исплату за учеснике
Узраст од 18 до 80 · Оба пола · Ажурирано 11. 6. 2026. · NCT06291155HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Arcturus Healthcare, PLC, Troy Internal Medicine Research Division, Troy
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 23. 4. 2026. · NCT07546929Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.